USANA Health Sciences, Inc. (USNA) said, for fiscal 2020, the company now projects earnings per share in a range of $4.70 - $5.25, revised from prior guidance range of $4.00 - $4.90. Consolidated net sales are projected in a range of $1.05 billion - $1.10 billion, updated from prior guidance of $1.00 billion - $1.08 billion.
Second quarter earnings per share was $1.32 compared to $0.91, previous year. Analysts polled by Thomson Reuters expected the company to report profit per share of $1.08, for the quarter. Analysts' estimates typically exclude special items.
Second quarter net sales increased year-on-year to $258.99 million from $256.02 million. Analysts expected revenue of $256.33 million for the quarter.
The company ended the quarter with $227.4 million in cash and cash equivalents and no debt.
Shares of USANA Health Sciences were up nearly 3% after hours.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.